Abstract: Provided are a method and a system for processing a rare earth concentrate ore. The method comprises (1) mixing the rare earth concentrate ore and concentrated sulfuric acid, thereby obtaining a mixed slurry and a first fluorine-containing gas; (2) mixing the mixed slurry and an initiator liquid for acidolysis, thereby obtaining a clinker and a second fluorine-containing gas; (3) subjecting the clinker to leaching with water, thereby obtaining a leached slurry; (4) subjecting the leached slurry to a solid-liquid separation, thereby obtaining a filtrate and a leached slag, and recycling the leached slag to step (2) for acidolysis again.

Abstract: Provided is a device for continuously decomposing a rare earth concentrate ore. The device includes a body, a bidirectional propeller and a driving assembly. The body has a material inlet, two liquid inlets and two exhaust gas outlets disposed at the top of the body, two material outlets disposed at the bottom of the body and a heat preservation chamber provided inside a side wall of the body. The bidirectional propeller is provided in the body and extends along a length direction of the body. The driving assembly is connected to the rotating shaft.

Abstract: An optical line terminal (OLT) device virtualization method and a related device, the method including creating a plurality of virtual OLT systems on an OLT device, and determining system resources of each of the plurality of virtual OLT systems according to a preset rule. The system resources include a physical resource and a logical resource, and physical resources and logical resources of the plurality of virtual OLT systems are different from each other.

Abstract: Provided is a device for continuously decomposing a rare earth concentrate ore. The device includes a body, a bidirectional propeller and a driving assembly. The body has a material inlet, two liquid inlets and two exhaust gas outlets disposed at the top of the body, two material outlets disposed at the bottom of the body and a heat preservation chamber provided inside a side wall of the body. The bidirectional propeller is provided in the body and extends along a length direction of the body. The driving assembly is connected to the rotating shaft.

Abstract: Provided are a method and a system for processing a rare earth concentrate ore. The method comprises (1) mixing the rare earth concentrate ore and concentrated sulfuric acid, thereby obtaining a mixed slurry and a first fluorine-containing gas; (2) mixing the mixed slurry and an initiator liquid for acidolysis, thereby obtaining a clinker and a second fluorine-containing gas; (3) subjecting the clinker to leaching with water, thereby obtaining a leached slurry; (4) subjecting the leached slurry to a solid-liquid separation, thereby obtaining a filtrate and a leached slag, and recycling the leached slag to step (2) for acidolysis again.

Abstract: An optical line terminal (OLT) device virtualization method and a related device, the method including creating a plurality of virtual OLT systems on an OLT device, and determining system resources of each of the plurality of virtual OLT systems according to a preset rule. The system resources include a physical resource and a logical resource, and physical resources and logical resources of the plurality of virtual OLT systems are different from each other.

Abstract: The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Pro104) antibodies that bind to Pro104 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro104 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro104 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro104 antibodies. The invention encompasses a method of producing the anti-Pro104 antibodies. Other aspects of the invention are a method of killing a Pro104-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro104 antibody and a method of alleviating or treating a Pro104-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro104 antibody to the mammal.

Abstract: The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Pro104) antibodies that bind to Pro104 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro104 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro104 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro104 antibodies. The invention encompasses a method of producing the anti-Pro104 antibodies. Other aspects of the invention are a method of killing a Pro104-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro104 antibody and a method of alleviating or treating a Pro104-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro104 antibody to the mammal.

Abstract: The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Pro104) antibodies that bind to Pro104 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro104 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro104 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro104 antibodies. The invention encompasses a method of producing the anti-Pro104 antibodies. Other aspects of the invention are a method of killing a Pro104-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro104 antibody and a method of alleviating or treating a Pro104-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro104 antibody to the mammal.

Abstract: The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Pro104) antibodies that bind to Pro 104 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro104 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro 104 antibody, as well as an expression vector comprising the isolated'l nucleic acid. Also provided are cells that produce the anti-Pro 104 antibodies. The invention encompasses a method of producing the anti-Pro 104 antibodies. Other aspects of the invention are a method of killing a Pro 104-expressing cancer cell, comprising contacting the cancer cell with an antiPro104 antibody and a method of alleviating or treating a Pro 104-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro 104 antibody to the mammal.